Hwang Do Won, Kang Joo Hyun, Chang Young Soo, Jeong Jae Min, Chung June-Key, Lee Myung Chul, Kim Soonhag, Lee Dong Soo
Programs in Neuroscience, Seoul National University, Seoul, Korea.
J Nucl Med. 2007 Apr;48(4):588-95. doi: 10.2967/jnumed.106.036533.
For noninvasive monitoring of cellular status by dual reporters, a dual membrane protein reporter system was developed and its in vivo applicability was examined. Human sodium iodide symporter (hNIS) and mutant dopamine D(2) receptor (D(2)R) transgenes were chosen considering their complementarity.
pIRES-hNIS/D(2)R containing NIS and D(2)R linked with an internal ribosomal entry site (IRES) was constructed and transfected into human hepatoma SK-Hep1 and rat glioma C6 cells. The cell lines stably expressing hNIS and D(2)R (named SK-ND and C6-ND) were produced, which was confirmed by messenger RNA expression of reporter genes. The functional activities of hNIS and D(2)R were measured by (125)I uptake assay and (3)H-spiperone receptor-binding assays. A biodistribution study was performed on SK-ND tumor-bearing mice using (99m)Tc-pertechnetate and (3)H-spiperone. In vivo hNIS expression was examined using (99m)Tc-pertechnetate gamma-camera imaging and, D(2)R expression was examined using a (3)H-spiperone autoradiographic study.
(125)I uptake of SK-ND and C6-ND cell lines showed a maximum 97-fold and 43-fold increase, respectively, which were completely inhibited by KClO(4). Specific (3)H-spiperone binding to SK-ND and C6-ND cell homogenates was observed, which were completely inhibited by (+)-butaclamol. Among the dual reporter gene-expressing cell lines, the activities of both reporters were inversely correlated with each other. Competition assay of hNIS-expressing cells by D(2)R vector transfection and D(2)R-expressing cells by hNIS vector transfection showed a dose-dependent decrease of hNIS and D(2)R activities, respectively. In the biodistribution study, (99m)Tc-pertechnetate accumulated 10-fold and (3)H-spiperone accumulated 4-fold more in SK-ND tumors than that in parental SK tumors. In vivo imaging of (99m)Tc-pertechnetate persisted until 5 wk after the cell graft in SK-ND tumors. Autoradiographic study of brain tissues from these mice also revealed an accumulation of (3)H-spiperone in SK-ND tumors.
We developed a dual membrane-bound positron and gamma-imaging reporter system of hNIS and D(2)R. We observed its reporting capability in vitro and in vivo and elucidated that these 2 membrane protein reporters competed with each other in their expression. Although we expect that hNIS and D(2)R transgenes can complement each other as a dual reporter system, we suggest that one needs to validate the ratio of expression of the 2 membrane protein reporter transgenes for cellular status tracking.
为了通过双报告基因对细胞状态进行无创监测,开发了一种双膜蛋白报告系统,并检测了其在体内的适用性。考虑到它们的互补性,选择了人钠碘同向转运体(hNIS)和突变型多巴胺D(2)受体(D(2)R)转基因。
构建了包含与内部核糖体进入位点(IRES)相连的NIS和D(2)R的pIRES-hNIS/D(2)R,并将其转染到人肝癌SK-Hep1细胞和大鼠胶质瘤C6细胞中。产生了稳定表达hNIS和D(2)R的细胞系(命名为SK-ND和C6-ND),这通过报告基因的信使RNA表达得到证实。通过(125)I摄取试验和(3)H-螺哌隆受体结合试验测量hNIS和D(2)R的功能活性。使用(99m)Tc-高锝酸盐和(3)H-螺哌隆对荷SK-ND肿瘤的小鼠进行生物分布研究。使用(99m)Tc-高锝酸盐γ相机成像检查体内hNIS表达,并使用(3)H-螺哌隆放射自显影研究检查D(2)R表达。
SK-ND和C6-ND细胞系的(125)I摄取分别显示最大增加97倍和43倍,这被高氯酸钾完全抑制。观察到特异性(3)H-螺哌隆与SK-ND和C6-ND细胞匀浆结合,这被(+)-布他拉莫完全抑制。在双报告基因表达细胞系中,两种报告基因的活性彼此呈负相关。通过D(2)R载体转染对hNIS表达细胞的竞争试验和通过hNIS载体转染对D(2)R表达细胞的竞争试验分别显示hNIS和D(2)R活性呈剂量依赖性降低。在生物分布研究中,(99m)Tc-高锝酸盐在SK-ND肿瘤中的积累比亲本SK肿瘤多10倍,(3)H-螺哌隆积累多4倍。(99m)Tc-高锝酸盐的体内成像在SK-ND肿瘤细胞移植后持续到5周。对这些小鼠脑组织的放射自显影研究也显示(3)H-螺哌隆在SK-ND肿瘤中积累。
我们开发了一种hNIS和D(2)R的双膜结合正电子和γ成像报告系统。我们在体外和体内观察到了它的报告能力,并阐明这两种膜蛋白报告基因在表达上相互竞争。尽管我们期望hNIS和D(2)R转基因作为双报告系统可以相互补充,但我们建议需要验证这两种膜蛋白报告基因转基因的表达比例以用于细胞状态追踪。